|
Market Closed -
Oslo Bors
10:45:00 2026-10-21 EDT
|
5-day change | 1st Jan Change | ||
| 287.00 NOK | +1.06% |
|
+0.70% | +10.81% |
| 10-20 | SB1 Markets raises price target on Medistim to 260 Norwegian kroner (230), reiterates neutral | FW |
| 09-20 | Medistim ASA(OB:MEDI) added to S&P Global BMI Index | CI |
| Market Cap | 5.25B 562M 499M 461M 419M 782M 53.03B 798M 5.52B 2.17B 27.88B 2.11B 2.06B 88.41B | P/E 2026 * |
28.9x | P/E 2027 * | 26.6x |
|---|---|---|---|---|---|
| Enterprise Value | 5.11B 547M 486M 449M 408M 762M 51.64B 777M 5.37B 2.12B 27.14B 2.05B 2.01B 86.09B | EV / Sales 2026 * |
6.43x | EV / Sales 2027 * | 5.87x |
| Free-Float |
69.57% | Yield 2026 * |
3.01% | Yield 2027 * | 3.12% |
| Markets | Quality | ||
|---|---|---|---|
Oslo Bors
| MEDI | Real-time | |
CBOE
| MEDIo | Real-time | |
|
Nasdaq Stockholm
| MEDIO | Delayed | |
|
Nasdaq Stockholm
| MEDIO | End-of-day quote | |
|
Boerse Muenchen
| MD1 | Real-time | |
|
CBOE
| 0OCD | Real-time | |
|
Deutsche Boerse AG
| MD1 | Delayed | |
|
Börse Stuttgart
| MD1 | Delayed |
Last Transcript: Medistim ASA
| 1 day | +1.06% | ||
| 1 week | +0.70% | ||
| Current month | +13.44% | ||
| 1 month | +15.73% | ||
| 3 months | +26.99% | ||
| 6 months | +21.61% | ||
| Current year | +10.81% |
| 1 week | 274 |  | 289 |
| 1 month | 245 | | 289 |
| Current year | 186.5 | | 289 |
| 1 year | 186.5 | | 292 |
| 3 years | 130 | | 292 |
| 5 years | 130 | | 402.5 |
| 10 years | 60 | | 409 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 62 | 2009-08-31 | |
| Director of Finance/CFO | - | 2000-12-31 | |
Jonas Tysso
CTO | Chief Tech/Sci/R&D Officer | - | 2024-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 78 | 1999-12-31 | |
Tove Raanes
BRD | Director/Board Member | 49 | 2013-12-31 |
| Director/Board Member | 56 | 2023-03-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 3/4/25 | Buy | Chairman | 860,735 | 4.6939% | ||
| 1/27/25 | Buy | Chairman | 45,000 | 0.2454% | ||
| 1/9/25 | Buy | Chairman | 30,000 | 0.1636% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.06% | +0.70% | +20.59% | +55.14% | 552M | |
| +0.97% | +4.67% | +27.61% | +49.46% | 254B | |
| +4.29% | +4.95% | +12.22% | +13.62% | 158B | |
| -2.26% | +1.44% | -6.62% | +60.40% | 155B | |
| -2.35% | +2.77% | -55.72% | -11.07% | 66.06B | |
| +0.59% | +6.27% | +12.12% | +59.96% | 51.6B | |
| +0.65% | +4.48% | -13.77% | -9.33% | 51.82B | |
| +0.12% | +3.67% | +17.41% | +27.23% | 50.89B | |
| +2.74% | +3.58% | +24.30% | +62.73% | 48.78B | |
| +3.31% | +6.59% | +33.30% | +80.36% | 43.51B | |
| Average | +0.98% | +3.00% | +7.14% | +38.85% | 87.97B | |
| Weighted average by Cap. | +1.15% | +3.19% | +8.73% | +38.55% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 795M 85.04M 75.61M 69.86M 63.39M 118M 8.03B 121M 836M 329M 4.22B 319M 312M 13.39B | 868M 92.79M 82.5M 76.23M 69.17M 129M 8.76B 132M 912M 359M 4.61B 348M 341M 14.61B |
| Net income | 182M 19.41M 17.26M 15.95M 14.47M 27.04M 1.83B 27.58M 191M 75.17M 964M 72.79M 71.27M 3.06B | 202M 21.61M 19.21M 17.75M 16.11M 30.1M 2.04B 30.7M 212M 83.66M 1.07B 81.01M 79.32M 3.4B |
| Net Debt | -138M -14.76M -13.12M -12.13M -11M -20.56M -1.39B -20.97M -145M -57.15M -733M -55.34M -54.19M -2.32B | -158M -16.85M -14.98M -13.84M -12.56M -23.47M -1.59B -23.93M -166M -65.23M -836M -63.17M -61.84M -2.65B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-21 | NOK 287.00 | +1.06% | 3,427 |
| 26-10-20 | NOK 284.00 | +0.35% | 2,542 |
| 26-10-19 | NOK 283.00 | +0.71% | 6,434 |
| 26-10-16 | NOK 281.00 | +1.81% | 33,381 |
| 26-10-15 | NOK 276.00 | -2.82% | 8,424 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- MEDI Stock
Select your edition
All financial news and data tailored to specific country editions
